1. US Food and Drug Administration. Pathway to global product safety and quality. Available at: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/GlobalProductPathway/default.htm. Accessed October 17, 2012.
2. EvaluatePharma. World preview 2018: embracing the patent cliff. Available at: http://www.evaluatepharma.com/worldpreview2018.aspx. Accessed October 17, 2012.
3. US Food and Drug Administration. FDA approves Kalydeco to treat rare form of cystic fibrosis [press release]. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm289633.htm. Accessed October 17, 2012.
4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline: ethnic factors in the acceptability of foreign clinical data E5(R1). Available at: http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/ethnic-factors-in-the-acceptability-of-foreign-clinical-data.html. Accessed October 17, 2012.
5. Tohkin M. Comparative studies of pharmacokinetics among East Asian populations. Paper presented at: APEC Multi-regional Clinical Trials Tokyo Workshop; November 1, 2011; Tokyo, Japan.